- Home
- PSHG vs COCH Comparison
PSHG vs COCH Comparison
Compare PSHG & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSHG
- COCH
- Stock Information
- Founded
- PSHG 2010
- COCH 1995
- Country
- PSHG Greece
- COCH United States
- Employees
- PSHG N/A
- COCH N/A
- Industry
- PSHG Marine Transportation
- COCH Blank Checks
- Sector
- PSHG Consumer Discretionary
- COCH Finance
- Exchange
- PSHG Nasdaq
- COCH Nasdaq
- Market Cap
- PSHG 22.8M
- COCH 25.2M
- IPO Year
- PSHG N/A
- COCH N/A
- Fundamental
- Price
- PSHG $1.88
- COCH $1.32
- Analyst Decision
- PSHG
- COCH Strong Buy
- Analyst Count
- PSHG 0
- COCH 2
- Target Price
- PSHG N/A
- COCH $9.25
- AVG Volume (30 Days)
- PSHG 119.3K
- COCH 782.8K
- Earning Date
- PSHG 11-06-2025
- COCH 11-13-2025
- Dividend Yield
- PSHG N/A
- COCH N/A
- EPS Growth
- PSHG 5.84
- COCH N/A
- EPS
- PSHG 1.56
- COCH N/A
- Revenue
- PSHG $84,042,000.00
- COCH $222,000.00
- Revenue This Year
- PSHG N/A
- COCH $4.27
- Revenue Next Year
- PSHG $17.95
- COCH $23.37
- P/E Ratio
- PSHG $1.15
- COCH N/A
- Revenue Growth
- PSHG N/A
- COCH N/A
- 52 Week Low
- PSHG $1.31
- COCH $1.06
- 52 Week High
- PSHG $2.34
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- PSHG 50.87
- COCH 49.22
- Support Level
- PSHG $1.77
- COCH $1.23
- Resistance Level
- PSHG $1.95
- COCH $1.37
- Average True Range (ATR)
- PSHG 0.09
- COCH 0.08
- MACD
- PSHG -0.01
- COCH 0.02
- Stochastic Oscillator
- PSHG 47.83
- COCH 69.57
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.